(Q33193592)

23 July 2017

title

Methanethiosulfonate derivatives of rhodamine and verapamil activate human P-glycoprotein at different sites (English)

1 reference

23 July 2017

1 reference

Tip W Loo

1

1 reference

23 July 2017

M Claire Bartlett

series ordinal

2

1 reference

23 July 2017

David M Clarke

series ordinal

3

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

Journal of Biological Chemistry

23 July 2017

published in

1 reference

23 July 2017

volume

278

1 reference

23 July 2017

issue

50

1 reference

23 July 2017

page(s)

50136-50141

1 reference

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Molecular genetic analysis and biochemical characterization of mammalian P-glycoproteins involved in multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

ABC Transporters: From Microorganisms to Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

The human ATP-binding cassette (ABC) transporter superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Membrane topology of a cysteine-less mutant of human P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Transmembrane organization of mouse P-glycoprotein determined by epitope insertion and immunofluorescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Covalent modification of human P-glycoprotein mutants containing a single cysteine in either nucleotide-binding fold abolishes drug-stimulated ATPase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

The minimum functional unit of human P-glycoprotein appears to be a monomer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

The "LSGGQ" motif in each nucleotide-binding domain of human P-glycoprotein is adjacent to the opposing walker A sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

P-glycoprotein catalytic mechanism: studies of the ADP-vanadate inhibited state

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Defining the drug-binding site in the human multidrug resistance P-glycoprotein using a methanethiosulfonate analog of verapamil, MTS-verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Location of the rhodamine-binding site in the human multidrug resistance P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

The packing of the transmembrane segments of human multidrug resistance P-glycoprotein is revealed by disulfide cross-linking analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Determining the dimensions of the drug-binding domain of human P-glycoprotein using thiol cross-linking compounds as molecular rulers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Substrate-induced conformational changes in the transmembrane segments of human P-glycoprotein. Direct evidence for the substrate-induced fit mechanism for drug binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Drug binding in human P-glycoprotein causes conformational changes in both nucleotide-binding domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Drug-stimulated ATPase activity of human P-glycoprotein is blocked by disulfide cross-linking between the nucleotide-binding sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Cross-linking of human multidrug resistance P-glycoprotein by the substrate, tris-(2-maleimidoethyl)amine, is altered by ATP hydrolysis. Evidence for rotation of a transmembrane helix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Vanadate trapping of nucleotide at the ATP-binding sites of human multidrug resistance P-glycoprotein exposes different residues to the drug-binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

The transmembrane domains of the human multidrug resistance P-glycoprotein are sufficient to mediate drug binding and trafficking to the cell surface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

A novel electron paramagnetic resonance approach to determine the mechanism of drug transport by P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Proximity of bound Hoechst 33342 to the ATPase catalytic sites places the drug binding site of P-glycoprotein within the cytoplasmic membrane leaflet

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Characterization of two pharmacophores on the multidrug transporter P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Allosteric modulation of human P-glycoprotein. Inhibition of transport by preventing substrate translocation and dissociation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Permanent Activation of the Human P-glycoprotein by Covalent Modification of a Residue in the Drug-binding Site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Rapid purification of human P-glycoprotein mutants expressed transiently in HEK 293 cells by nickel-chelate chromatography and characterization of their drug-stimulated ATPase activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

P-glycoprotein. Associations between domains and between domains and molecular chaperones

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

P-glycoprotein Is Stably Inhibited by Vanadate-induced Trapping of Nucleotide at a Single Catalytic Site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Simultaneous binding of two different drugs in the binding pocket of the human multidrug resistance P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Studies with novel Pdr5p substrates demonstrate a strong size dependence for xenobiotic efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Structure of MsbA from Vibrio cholera: a multidrug resistance ABC transporter homolog in a closed conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

ATPase activity of the MsbA lipid flippase of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Crystal structure of the transcription activator BmrR bound to DNA and a drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Structural mechanisms of QacR induction and multidrug recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Molecular dissection of the human multidrug resistance P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Identification of Residues in the Drug-binding Site of Human P-glycoprotein Using a Thiol-reactive Substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Identification of Residues in the Drug-binding Domain of Human P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Identification of Residues within the Drug-binding Domain of the Human Multidrug Resistance P-glycoprotein by Cysteine-scanning Mutagenesis and Reaction with Dibromobimane

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Drug-stimulated ATPase Activity of Human P-glycoprotein Requires Movement between Transmembrane Segments 6 and 12

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Correction of Defective Protein Kinesis of Human P-glycoprotein Mutants by Substrates and Modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Inhibition of Oxidative Cross-linking between Engineered Cysteine Residues at Positions 332 in Predicted Transmembrane Segments (TM) 6 and 975 in Predicted TM12 of Human P-glycoprotein by Drug Substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

Communication between multiple drug binding sites on P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

A method for the determination of inorganic phosphate in the presence of labile organic phosphate and high concentrations of protein: application to lens ATPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310448200

21 January 2018

Identifiers

DOI

10.1074/JBC.M310448200

1 reference

23 July 2017

1 reference